Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria

Clinical trial NCT03190694 · COMPLETED

Trial details

NCT number: NCT03190694
Sponsor: Hiddo Lambers Heerspink
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Kidney Diseases Proteinuria

Start date: 2017-11-12
Primary completion: 2019-11-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.